Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
Closed Solicitation Posted
This opportunity was awarded. See its 4 award notices in the notice history.
- Solicitation number
- 75F40124R00002
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of Acquisition and Grant Services is seeking contractors for the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The agency requires large-scale, near real-time patient-level data from administrative claims, electronic health records, and linked claims-EHR data sources covering tens of millions of individuals nationwide, with full access to medical records. Key objectives include developing data quality assessment plans, providing analytic capabilities for epidemiologic studies, obtaining medical records, linking to immunization information systems, and managing overall program operations. Responses are due by August 5, 2024, and the contract will use a variety of fixed-price, time and materials, and labor hour task orders.
This is an unrestricted solicitation with no set-aside. The incumbent contractors for the previous BEST 3 IDIQ contract were The Lewin Group, IQVIA, and CVS Health. The contract has a 5-year ordering period, a $10,000 guaranteed minimum, and an estimated maximum of $75 million. The place of performance is the United States.
Notice text
4 versions
Update #4 · Latest ·
7/30/2024: See amendment 3 attached.
7/11/2024: See amendment 2 attached.
7/8/2024: See amendment 1 attached.
See attached solicitation documents.
Update #3 ·
7/11/2024: See amendment 2 attached.
7/8/2024: See amendment 1 attached.
See attached solicitation documents.
Update #2 ·
7/8/2024: See amendment 1 attached.
See attached solicitation documents.
Update #1 ·
See attached solicitation documents.
Files
| File | Type | Posted |
|---|---|---|
| Amendment 3 Attachment 1 HHSAR Clauses and Provisions.docx | DOCX document | |
| Amendment 3 Attachment 2 BEST 3 Task Order 1 SOW.docx | DOCX document | |
| Amendment 3.pdf | ||
| Amendment 3 Attachment 3 Solicitation 75F40124R00002 BEST 3.pdf | ||
| amendment 2 attachment 1 Solicitation 75F40124R00002 BEST 3.pdf | ||
| amendment 2.pdf | ||
| amendment 1.pdf | ||
| Attachment 1 BEST3 IDIQ PWS.docx | DOCX document | |
| Attachment 5 - Past Performance Evaluation Questionnaire.docx | DOCX document | |
| Attachment 2 BEST 3 Task Order 1 SOW.docx | DOCX document | |
| Attachment 3 - Wage Determination.pdf | ||
| Attachment 6 - Sample Client Letter for Past Performance.docx | DOCX document | |
| 75F40124R00002.pdf | ||
| Attachment 4 FDA Form 3398.pdf |
Show all 14
Notice history
5 of 6 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity